Literature DB >> 31672865

Clonal hematopoiesis in human aging and disease.

Siddhartha Jaiswal1, Benjamin L Ebert2,3.   

Abstract

As people age, their tissues accumulate an increasing number of somatic mutations. Although most of these mutations are of little or no functional consequence, a mutation may arise that confers a fitness advantage on a cell. When this process happens in the hematopoietic system, a substantial proportion of circulating blood cells may derive from a single mutated stem cell. This outgrowth, called "clonal hematopoiesis," is highly prevalent in the elderly population. Here we discuss recent advances in our knowledge of clonal hematopoiesis, its relationship to malignancies, its link to nonmalignant diseases of aging, and its potential impact on immune function. Clonal hematopoiesis provides a glimpse into the process of mutation and selection that likely occurs in all somatic tissues.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Year:  2019        PMID: 31672865     DOI: 10.1126/science.aan4673

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  161 in total

Review 1.  Characterizing the ecological and evolutionary dynamics of cancer.

Authors:  Nastaran Zahir; Ruping Sun; Daniel Gallahan; Robert A Gatenby; Christina Curtis
Journal:  Nat Genet       Date:  2020-07-27       Impact factor: 38.330

Review 2.  Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis.

Authors:  Ira Tabas; Karin E Bornfeldt
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

3.  Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulation.

Authors:  L Alexander Liggett; Matthew D Galbraith; Keith P Smith; Kelly D Sullivan; Ross E Granrath; Belinda Enriquez-Estrada; Kohl T Kinning; Jessica R Shaw; Angela L Rachubinski; Joaquin M Espinosa; James DeGregori
Journal:  Blood Adv       Date:  2021-04-13

4.  FOXO activity adaptation safeguards the hematopoietic stem cell compartment in hyperglycemia.

Authors:  Vinothini Govindarajah; Jung-Mi Lee; Michael Solomon; Bryan Goddard; Ramesh Nayak; Kalpana Nattamai; Hartmut Geiger; Nathan Salomonis; Jose A Cancelas; Damien Reynaud
Journal:  Blood Adv       Date:  2020-11-10

Review 5.  Hematopoiesis and Cardiovascular Disease.

Authors:  Wolfram C Poller; Matthias Nahrendorf; Filip K Swirski
Journal:  Circ Res       Date:  2020-04-09       Impact factor: 17.367

Review 6.  Unraveling Hematopoiesis through the Lens of Genomics.

Authors:  L Alexander Liggett; Vijay G Sankaran
Journal:  Cell       Date:  2020-09-17       Impact factor: 41.582

7.  Large Copy-Number Variants in UK Biobank Caused by Clonal Hematopoiesis May Confound Penetrance Estimates.

Authors:  Marcus Tuke; Jessica Tyrrell; Katherine S Ruth; Robin N Beaumont; Andrew R Wood; Anna Murray; Timothy M Frayling; Michael N Weedon; Caroline F Wright
Journal:  Am J Hum Genet       Date:  2020-06-22       Impact factor: 11.025

8.  Impact of sex and histology on the therapeutic effects of fluoropyrimidines and oxaliplatin plus bevacizumab for patients with metastatic colorectal cancer in the SOFT trial.

Authors:  Yasuhide Yamada; Kei Muro; Keiichi Takahashi; Hideo Baba; Yoshito Komatsu; Taroh Satoh; Masahiro Goto; Hideyuki Mishima; Masahiko Watanabe; Yuh Sakata; Satoshi Morita; Yasuhiro Shimada; Naruhito Takenaka; Tadashi Hirooka; Kenichi Sugihara
Journal:  Glob Health Med       Date:  2020-08-31

Review 9.  Clonal expansion in non-cancer tissues.

Authors:  Nobuyuki Kakiuchi; Seishi Ogawa
Journal:  Nat Rev Cancer       Date:  2021-02-24       Impact factor: 60.716

Review 10.  Clonal hematopoiesis as a model for premalignant changes during aging.

Authors:  David P Steensma; Benjamin L Ebert
Journal:  Exp Hematol       Date:  2019-12-12       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.